Company Filing History:
Years Active: 2018
Title: Sabine Defays: Innovator in TNF Modulation
Introduction
Sabine Defays is a notable inventor based in Brussels, Belgium. She has made significant contributions to the field of biopharmaceuticals, particularly in the modulation of tumor necrosis factor (TNF) activity. With a total of 2 patents, her work is pivotal in addressing various human ailments.
Latest Patents
Her latest patents include "Tetrahydroimidazopyridine derivatives as modulators of TNF activity." This patent describes a series of substituted 5,6,7,8-tetrahydroimidazo[1,2-α]pyridine derivatives that serve as potent modulators of human TNFα activity. These compounds are beneficial in the treatment and prevention of various disorders, including autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders.
Another significant patent is "Fused tricyclic benzimidazoles derivatives as modulators of TNF activity." This patent outlines a series of tricyclic benzimidazole derivatives, particularly dihydro-1H-imidazo [1,2-a]benzimidazole and its analogs, which also act as potent modulators of human TNFα activity. Similar to her previous work, these compounds are aimed at treating a wide range of human ailments.
Career Highlights
Sabine Defays is currently employed at UCB Biopharma Sprl, where she continues to innovate in the field of biopharmaceuticals. Her research focuses on developing new therapeutic agents that can effectively modulate TNF activity, which is crucial for treating various diseases.
Collaborations
Throughout her career, Sabine has collaborated with notable colleagues, including Jag Paul Heer and Victoria Elizabeth Jackson. These collaborations have further enhanced her research and development efforts in the biopharmaceutical sector.
Conclusion
Sabine Defays is a prominent inventor whose work in TNF modulation has the potential to significantly impact the treatment of various human ailments. Her contributions to the field are invaluable, and her ongoing research promises to lead to further advancements in biopharmaceuticals.